OvaScience CEO Michelle Dipp Elected as Young Global Leader by World Economic Forum
Dr. Dipp joins other notable YGLs, including:
“The YGLs include the world’s most pioneering leaders who have developed
in their journey to produce positive, tangible impacts in their
countries, industries and societies,” said
“This is a great opportunity to join other global leaders who have already had such a positive effect on and remain committed to improving the lives of others,” said Dr. Dipp. “I look forward to what we can accomplish together to address the challenges of and expand the opportunities for building a greater global community.”
To learn more about the YGL community, visit http://www.weforum.org/community/forum-young-global-leaders.
This press release includes forward-looking statements about the Company’s business and development plans for the AUGMENT treatment and its two fertility treatments in development. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: the possibility that international IVF clinics that we work with may determine not to begin or continue providing the AUGMENT treatment for commercial or other reasons; our expectation that the AUGMENT treatment and OvaPrime treatment meet the requirements of a class of products exempt from premarket review and approval under applicable regulations in those countries where we have launched or plan to introduce the AUGMENT treatment and plan to introduce the OvaPrime treatment; the science underlying our treatment and treatments in development (including the AUGMENT, OvaPrime and OvaTure treatments), which is unproven; our ability to obtain regulatory approval where necessary for our potential treatments; our ability to develop our potential treatments, including the OvaPrime and OvaTure treatments, on the timelines we expect, if at all; our ability to commercialize the AUGMENT treatment and our potential treatments, including the OvaPrime treatment, on the timelines we expect, if at all; as well as those risks more fully discussed in the “Risk Factors” section of our most recently filed Quarterly Report on Form 10-Q and/or Annual Report on Form 10-K. The forward-looking statements contained in this press release reflect our current views with respect to future events. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our view as of any date subsequent to the date hereof.
Cara Mayfield, Director, Corporate Communications, 617-714-9638